New York, NY [October 1, 2025]—Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University Chobanian & Avedisian School of Medicine, have developed a software platform to help scientists more easily analyze the molecular structure of tissue in both healthy and disease states. Details on the platform, called Giotto Suite, were reported in the October 1 online issue of Nature Methods [DOI: 10.1038/s41592-025-02817-w].
In recent years, new technologies have made it possible to capture detailed maps of RNA and proteins within intact tissues—a field known as spatial omics. These advances are providing valuable insight into how cells behave and interact in different tissue microenvironments, which is especially important for understanding conditions such as cancer, neurodegenerative diseases, and immune disorders.
"While spatial omics technologies are generating incredibly rich data about the molecular landscape of tissues, the real challenge now lies in analyzing and interpreting that data," says co-senior corresponding author Guo-Cheng Yuan, PhD , Professor of Genetics and Genomic Sciences, at the Icahn School of Medicine at Mount Sinai. "The biggest obstacle is no longer generating the information—it's making sense of it. Biologists need tools that can keep pace with the growing complexity and scale of these datasets and help them draw meaningful conclusions. We wanted to create a tool that not only simplifies the analysis process, but also adapts to different types of spatial data and workflows, so researchers can focus on the science rather than the technical hurdles."
To meet this need, the research teams created Giotto Suite, a suite of modular software tools built in R, a widely used programming language for data analysis. The tool is designed to work with spatial data from any platform and supports a broad range of analyses, including data integration across different types of measurements and resolutions. Its flexible structure also allows users to begin analysis from multiple points, depending on their research needs, say the investigators.
The researchers cautioned that the current version includes only a subset of available analytical methods, which may not suit every research question. They emphasized, however, that the platform is intended to evolve and that they plan to continue expanding its features, enhancing its interoperability with external software packages, and offering training and support to the research community.
Looking ahead, the researchers plan to apply Giotto Suite in their own studies of cancer and neurodegenerative diseases, while continuing to refine the tool based on feedback from the scientific community. The tool is freely available to researchers at http://giottosuite.com , and the team hopes it will encourage wider use of spatial omics technologies in biomedical research.
The paper is titled "Giotto Suite: a multi-scale and technology-agnostic spatial multi-omics analysis ecosystem."
The study's authors, as listed in the journal, are Jiaji George Chen, Joselyn Cristina Chávez-Fuentes, Matthew O'Brien, Junxiang Xu, Edward Ruiz, Wen Wang, Iqra Amin, Jeffrey Sheridan, Sujung Crystal Shin, Sanjana Varada Hasyagar, Irzam Sarfraz, Pratishtha Guckhool, Adriana Sistig, Veronica Jarzabek, Guo-Cheng Yuan, and Ruben Dries.
This work was supported by the Chan Zuckerberg Initiative's Essential Open Source Software for Science Program (2022-252544); The Crazy 8 Initiative from the Alex's Lemonade Stand Foundation for Childhood Cancer; and the National Institutes of Health (NIH) RF1MH128970, RF1MH133703, R01AG066028.
